A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.
MedPage Today on MSN
Cannabinoids for Mental, Substance Use Disorders 'Rarely Justified,' Study Suggests
Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...
Positive Phase 2b Results from the CAN-002 Study of PP-01, an investigational product intended to mitigate Cannabis Withdrawal Syndrome in patients with Cannabis Use Disorder PHOENIXVILLE, Pa., June ...
A drug approved by the FDA for smoking cessation was associated with significant reductions in cannabis use only in men with cannabis use disorder (CUD), a new trial showed. Following 12 weeks of ...
Heavy users of cannabis who experience withdrawal symptoms such as nervousness and cravings when they quit are likely to use again sooner than their peers, a new study finds. Researchers at the ...
New research shows even infrequent pot use during adolescence is linked to increased risk of mental-health disorders and poor academic performance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results